Today news
About the same in other media
Lupin gets USFDA nod to market generic skin treatment medication
Reading now: 359
Lupin on Wednesday said its American subsidiary has received an approval from the US health regulator to market a generic product used for treatment of skin issues. New Jersey-based Novel Laboratories Inc has received the approval from the US Food and Drug Administration (USFDA) for Fluocinolone Acetonide Topical Oil, Lupin said in a statement.
The product is the generic version of Hill Dermaceuticals Inc's Derma-Smoothe/FS Topical Oil. Lupin said the product will be manufactured at its Somerset facility in the US.
As per the IQVIA MAT March 2023 data, Fluocinolone Acetonide Topical Oil had estimated annual sales of USD 9 million in the US. Lupin shares were trading 0.67 per cent down at Rs 981.65 apiece on the BSE.
. Read more on economictimes.indiatimes.comAbout this in other media
Coinbase gets approval to offer crypto futures to eligible US customers economictimes.indiatimes.com /1 year ago
Italy gets back 266 antiquities from New York seizures after collector approaches Houston museum abcnews.go.com /1 year ago
Italy gets back 266 antiquities from New York seizures and Houston museum abcnews.go.com /1 year ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
